Please Wait.....
Report
Japan Contrast Enhanced Ultrasound Market Assessment, By Product [Equipment, Contrast Agents, Software and Services], By Application [Diagnostic Applications, Therapeutic Applications], By End-user [Hospitals and Surgical Centers, Diagnostic Imaging Centers, Ambulatory Surgery Center, Others], By Region, Opportunities and Forecast, FY2019-FY2033F
Market Report I 2025-06-16 I 124 Pages I Market Xcel - Markets and Data
Japan contrast enhanced ultrasound market is projected to witness a CAGR of 6.61% during the forecast period FY2026-FY2033, growing from USD 90.44 million in FY2025 to USD 150.86 million in FY2033. Growing prevalence of liver and cardiovascular diseases in Japan is driving demand for Contrast Enhanced Ultrasound (CEUS) as a safer, non-invasive diagnostic tool. Rising awareness among clinicians and patients, combined with advancements in ultrasound technology, is boosting its adoption across hospitals and imaging centers. Additionally, government support for radiation-free imaging aligns with CEUS benefits, further encouraging its integration into routine diagnostics.
Rising Prevalence of Chronic Diseases and Geriatric Population
Japan is experiencing an increase in its aging population alongside a rising incidence of chronic illnesses, including liver, kidney, and cardiovascular diseases. Contrast-Enhanced Ultrasound (CEUS) has emerged as a favored diagnostic method in these fields due to its non-invasive nature, lack of ionizing radiation, and excellent safety profile, which is particularly advantageous for elderly and high-risk patients. It offers real-time vascular imaging, enabling healthcare providers to identify lesions and tumors with greater precision. The growing need for regular diagnostic assessments in chronic diseases further drives the adoption of CEUS. Moreover, Japan's healthcare system emphasizes early disease detection to minimize long-term care expenses, prompting hospitals to incorporate CEUS into their diagnostic offerings. For instance, according to Japan's Ministry of Internal Affairs and Communications, as of 2023, seniors (65+) made up 29.1% of the total population, highlighting the pressing need for chronic disease management solutions.
Technological Advancements and Integration with AI Fueling Growth
In Japan, Contrast-Enhanced Ultrasound (CEUS) is undergoing swift advancements, particularly through the incorporation of artificial intelligence (AI) and advanced imaging software. These innovations improve image quality, lessen reliance on operators, and facilitate real-time analysis, thereby increasing the efficiency and applicability of CEUS. Japanese companies are channeling investments into CEUS systems that feature AI-based lesion detection, automated quantification, and motion correction capabilities. The enhanced precision and diagnostic reliability provided by these systems are promoting their acceptance in hospitals and diagnostic facilities. Moreover, AI enhances the reproducibility of CEUS results-an important factor for widespread clinical implementation. These innovations align with Japan's broader focus on smart healthcare technologies to address labor shortages and improve patient outcomes. For example, Canon U.S.A., Inc., a leading global supplier of imaging solutions, has launched Aplio beyond, a versatile ultrasound system that combines clinical excellence, operational efficiency, and ergonomic design in a compact, quiet, and eco-friendly package. Tailored for ultrasound specialists working in hospitals, busy imaging centers, and advanced practices that manage substantial workloads and varied patient populations, it provides outstanding imaging capabilities for routine assessments, specialized investigations, and complex procedures.
Increasing Use of CEUS in Oncology and Liver Imaging
CEUS is gaining significant traction in oncology diagnostics, especially for liver cancer, which has high incidence rates in Japan. It offers superior lesion characterization, early tumor detection, and post-treatment follow-up capabilities, often outperforming CT or MRI in certain contexts. Given its ability to visualize micro-vascularization without nephrotoxic contrast agents, CEUS is now commonly used for patients with renal impairments-common among cancer patients. Hospitals are increasingly adopting CEUS for liver, breast, and prostate cancer screening, due to its repeatability and low risk. Moreover, CEUS-guided biopsies and ablations have improved precision and outcomes in cancer treatment. For example, in late 2023, researchers at Kyoto University published clinical outcomes showing that CEUS significantly improved the detection rate of hepatocellular carcinoma (HCC) in high-risk Japanese patients compared to conventional ultrasound.
Future Market Scenario (FY2026 - FY2033F)
The Japan Contrast Enhanced Ultrasound (CEUS) market is poised for strong growth due to increasing applications in liver disease diagnosis, oncology, and cardiovascular imaging. As Japan faces a high burden of chronic liver conditions and an aging population, demand for non-invasive, radiation-free diagnostic tools is surging. CEUS offers real-time, high-resolution imaging with minimal side effects, making it ideal for repeated use, especially among elderly and vulnerable patients. Technological advancements, rising healthcare expenditure, and a growing preference for point-of-care imaging are expected to further propel adoption. Additionally, collaborations between Japanese medical institutions and global imaging companies are accelerating CEUS-related clinical trials and technology integration, positioning the market for long-term growth in diagnostic and therapeutic applications
.
Key Players Landscape and Outlook
Key players in the contrast enhanced ultrasound industry utilize strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.
For instance, Canon U.S.A., Inc. partnered with Olympus to introduce their newest ultrasound device, the Aplio i800 EUS. This hybrid system is especially proficient in identifying small lesions in the pancreas, as stated by Akihiro Sano, the general manager of ultrasound systems at Canon during a press briefing in January 2024.
1. Project Scope and Definitions
2. Research Methodology
3. Impact of U.S. Tariffs
4. Executive Summary
5. Japan Contrast Enhanced Ultrasound Market Outlook, FY2019-FY2033F
5.1. Market Size Analysis & Forecast
5.1.1. By Value
5.1.2. By Volume
5.2. Market Share Analysis & Forecast
5.2.1. By Product
5.2.1.1. Equipment
5.2.1.2. Contrast Agents
5.2.1.2.1. Molecule-Targeted Microbubbles
5.2.1.2.2. Nanoparticle Microbubbles
5.2.1.3. Software and Services
5.2.2. By Application
5.2.2.1. Diagnostic Applications
5.2.2.1.1. Nephrology
5.2.2.1.2. Cardiology
5.2.2.1.3. Others
5.2.2.2. Therapeutic Applications
5.2.2.2.1. Cardiology
5.2.2.2.2. Oncology
5.2.2.2.3. Vascular
5.2.2.2.4. Others
5.2.3. By End-user
5.2.3.1. Hospitals And Surgical Centers
5.2.3.2. Diagnostic Imaging Centers
5.2.3.3. Ambulatory Surgery Center
5.2.3.4. Others
5.2.4. By Region
5.2.4.1. North [Hokkaido and Tohoku]
5.2.4.2. Central [Kanto and Chubu]
5.2.4.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2025)
5.3. Market Map Analysis, FY2025
5.3.1. By Product Type
5.3.2. By Application
5.3.3. By End-user
5.3.4. By Region
6. Value Chain Analysis
7. Demand Supply Analysis
8. Import and Export Analysis
9. Porter's Five Forces Analysis
10. PESTLE Analysis
11. Pricing Analysis
12. Market Dynamics
12.1. Market Drivers
12.2. Market Challenges
13. Market Trends and Developments
14. Regulatory Framework and Innovation
15. Competitive Landscape
15.1. Competition Matrix of Top 5 Market Leaders
15.2. SWOT Analysis for Top 5 Players
15.3. Key Players Landscape for Top 10 Market Players
15.3.1. Lantheus Medical Imaging, Inc.
15.3.1.1. Company Details
15.3.1.2. Key Management Personnel
15.3.1.3. Products and Services
15.3.1.4. Financials (As Reported)
15.3.1.5. Key Market Focus and Geographical Presence
15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
15.3.2. GE HealthCare Technologies Inc.
15.3.3. Bracco Imaging S.P.A.
15.3.4. Philips Holding USA Inc.
15.3.5. Siemens Medical Solutions USA, Inc.
15.3.6. Mindray Medical International Limited
15.3.7. Canon U.S.A., Inc.
15.3.8. Esaote S.P.A
15.3.9. Samsung Electronics Co., Ltd
15.3.10. Guerbet SA
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
16. Strategic Recommendations
17. About Us and Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security